Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Studies from S. Parry et al have provided new data on breast cancer
October 9th, 2008
In this recently published article, scientists in London, the United Kingdom conducted a study "To analyse the distribution of nestin expression in different breast tumours and to determine the prognostic impact of nestin expression. Nestin expression was immunohistochemically analysed in a cohort of 245 invasive breast cancer patients treated with therapeutic surgery followed by anthracycline-based chemotherapy using a semi-quantitative scoring system." "Nestin was exclusively expressed in grade III breast carcinoma and preferentially expressed in basal-like and triple negative cancers. Nestin-positive tumours displayed high proliferation rates and p53 nuclear...
Source: Women's Health Weekly (2008-10-09)
|
